3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Withdrawn
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
19
Carcinoid Tumor
7
Pheochromocytoma
6
Thyroid Carcinoma, Anaplastic
5
Pituitary Neoplasms
5
Paraganglioma
5
Insulinoma
5
Somatostatinoma
4
Vipoma
3
Serotonin Syndrome
3
Lung Neoplasms
3
Glucagonoma
3
Gastro-enteropancreatic neuroendocrine tumor
3
Gastrinoma
3
Carcinoma, Neuroendocrine
3
Carcinoma, Merkel Cell
3
Carcinoma, Medullary
3
Carcinoma, Islet Cell
3
Thyroid Neoplasms
2
Small Cell Lung Carcinoma
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Neoplasms, Unknown Primary
2
Neoplasms
2
Multiple Endocrine Neoplasia Type 1
2
Head and Neck Neoplasms
2
Growth Hormone-Secreting Pituitary Adenoma
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Interventions
telotristat ethyl
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Diarrhea
×
Endocrine
×
Clear all
NCT04713202
2023-02-10
NET-PACS
Big Ten Cancer Research Consortium
Phase 2
Withdrawn